Huanglian Jiedu decoction ameliorates Alzheimer’s disease by regulating calcium homeostasis via mitochondria-associated endoplasmic reticulum membranes

Articles in Press

Document Type : Original Article

Authors

Academy of Chinese Medical Sciences; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan University of Chinese Medicine, Zhengzhou 450046, China

10.22038/ijbms.2026.91869.19827

Abstract

Objective(s): Huanglian Jiedu decoction (HLJDD), a classic traditional Chinese medicine formula, is investigated for its protective effects against Alzheimer’s disease (AD). This study explored its mechanism in an AD cell model, focusing on calcium ion (Ca²⁺) homeostasis regulation via mitochondria-associated endoplasmic reticulum membranes (MAMs).
Materials and Methods: Mouse hippocampal HT22 cells were induced with 10 μmol·L⁻¹ Aβ₁₋₄₂ to establish the AD model, then divided into blank, model, and 15% HLJDD-containing serum intervention groups. Fluorescent dyes, qRT-PCR, western blotting, laser scanning confocal microscopy, and Annexin V-FITC/PI staining were used to detect intracellular reactive oxygen species (ROS), mitochondrial membrane potential, VDAC1/GRP75/IP3R (mRNA/protein levels), MAMs formation, intracellular Ca²⁺, and cell apoptosis, respectively.
Results: Aβ₁₋₄₂ reduced HT22 viability in a concentration-dependent manner, while HLJDD significantly improved viability. Compared to the model group, HLJDD evidently decreased ROS levels (P<0.001), elevated mitochondrial membrane potential (P<0.001), up-regulated GRP75  (mRNA/protein, P<0.05), down-regulated VDAC1/IP3R (mRNA/protein, P<0.05 or P<0.001), reduced MAMs (via lower ER-mitochondria co-localization, P<0.05), alleviated Ca²⁺ overload  (P<0.001), and lowered apoptosis.
Conclusion: HLJDD exerts protective anti-AD effects likely by reducing MAMs formation to alleviate intracellular Ca²⁺ overload, thereby lessening cell damage and apoptosis.

Keywords

Main Subjects

References

1.Alzheimer’s Disease International. World Alzheimer Report 2023 (EB/OL). (2023-09-21). https://www.alzint.org/u/World-Alzheimer-Report-2023. 
2. 2023 Alzheimer’s disease facts and figures. Alzheimers Dement 2023; 19: 1598-1695. 
3. Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future. Signal Transduct Target Ther 2023; 8: 248.
4. Congdon EE, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol 2018; 14: 399-415.
5. Wang N, Wang C, Zhao H, He Y, Lan B, Sun L, Gao Y. The MAMs structure and its role in cell death. Cells 2021; 10: 657.
6. Liu J, Yang J. Mitochondria-associated membranes: A hub for neurodegenerative diseases. Biomed Pharmacother 2022; 149: 112890.
7. Area-Gomez E, Schon EA. On the pathogenesis of Alzheimer’s disease: The MAM hypothesis. FASEB J 2017; 31: 864-867.
8. Yu W, Jin H, Huang Y. Mitochondria-associated membranes (MAMs): A potential therapeutic target for treating Alzheimer’s disease. Clin Sci (Lond) 2021; 135: 109-126.
9. Yao Xinmin, Li Xinxin, Zhou Jia, Wang Qi, Liu Guangzhou, Zhou Yanyan. Experimental research progress on Traditional Chinese Medicine in treatment of Alzheimer’s Disease by regulating and controlling calcium ions in steady state. Chin Arch Tradit Chin Med 2018; 36: 49-52. 
10. Annunziata I, Sano R, d’Azzo A. Mitochondria-associated ER membranes (MAMs) and lysosomal storage diseases. Cell Death Dis 2018; 9: 328.
11. Marchi S, Patergnani S, Missiroli S, Morciano G, Rimessi A, Wieckowski MR, et al. Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death. Cell Calcium 2018; 69: 62-72.
12. Li Jinying, Huang Qihui, Tao Yangu. The effect of Naohuandan on learning and memory function and intracellular calcium ion concentration in the hippocampal region of APP/PS1 double transgenic mice‌. J New Chin Med 2014; 46: 213-216. 
13.Liu Baoguang, Xie Miao, Dong Ying, Wu Hua, Li Yucheng, Pang Huijuan, et al. Research progress on mechanism of Huanglian Jiedu Decoction. Acta Chin Med 2022; 37: 1861-1868. 
14.Wang Fan, Cen Xiaoguang. The advance of Huanglian jiedu Decoction in prevention and cure of senile dementia. J Liaoning Univ Tradit Chin Med 2015; 17: 4. 
15. Xie Shuling, Peng Liyan, Yang Kun, Li Bin, Wu Wenbin. Research progress on the mechanism of Huanglian Jiedu Decoction in treating Alzheimer’s Disease. Chin J Inf Tradit Chin Med 2014; 21: 121-123. 
16. Zhang Yinghua, Lv Hanlin, Zhou Jianwen, Fan Li, Li Yang. Huanglian Jiedutang regulates HIF-1α/VEGF signaling pathway to improve learning and memory abilities of APP/PS1 transgenic mice. Chin J Exp Tradit Med Formulae 2024; 30: 59-65. 
17. Wang Junli, Zhang Huifang, Xu Xinzi, Wang Rui, Du Yaming, Liu Xin, et al. Mechanism study on Huanglian Jiedu Decoction improving neuronal damage in Tau/ APP / PS1 Transgenic AD Mice by Inhibiting NLRP3 Inflammasome. J Basic Chin Med 2024; 30: 986-991. 
18. Zhang Libing, Mei Yingbing, Xu Xinzi, Wang Rui, Zhang Zhuo, Ma Zuofeng. The effect of Huanglian Jiedu Decoction on astrocytic ODC1 and its potential role in learning and memory in APP/PS1 mice. J Sichuan Tradit Chin Med 2024; . 
19. Cárdenas C, Miller RA, Smith I, Bui T, Molgó J, Müller M, et al. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 2010; 142: 270-283.
20. Qi S, Yuan Y, Yang W, Su JY, Hao LY. Calcium dyshomeostasis and Alzheimer’s Disease. Acta Acad Med Sin 2024; 46: 592-602. 
Iranian Journal of Basic Medical Sciences

Articles in Press, Accepted Manuscript
Available Online from 10 May 2026

Files

Share

How to cite

Statistics